212 related articles for article (PubMed ID: 33166928)
1. Discovery of polypodiside as a Keap1-dependent Nrf2 activator attenuating oxidative stress and accumulation of extracellular matrix in glomerular mesangial cells under high glucose.
Yao H; Zhang N; Zhang W; Li J; Hua H; Li Y
Bioorg Med Chem; 2020 Dec; 28(24):115833. PubMed ID: 33166928
[TBL] [Abstract][Full Text] [Related]
2. Discovery of caffeoylisocitric acid as a Keap1-dependent Nrf2 activator and its effects in mesangial cells under high glucose.
Yao H; Zhang W; Yang F; Ai F; Du D; Li Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):178-188. PubMed ID: 34894983
[TBL] [Abstract][Full Text] [Related]
3. Swinhoeic acid from
Yao H; Kong M; Du D; Ai F; Li J; Li Y
Redox Rep; 2022 Dec; 27(1):230-238. PubMed ID: 36259553
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a coumarin derivative as Nrf2 activator mitigating oxidative stress and fibrosis in mesangial cells under high glucose.
Yao H; Zhang N; Zhang W; Li J; Hua H; Li Y
Bioorg Med Chem Lett; 2020 Oct; 30(20):127490. PubMed ID: 32791195
[TBL] [Abstract][Full Text] [Related]
5. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
6. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
7. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.
Qiao S; Liu R; Lv C; Miao Y; Yue M; Tao Y; Wei Z; Xia Y; Dai Y
Free Radic Biol Med; 2019 Dec; 145():118-135. PubMed ID: 31494242
[TBL] [Abstract][Full Text] [Related]
8. CKIP-1 ameliorates high glucose-induced expression of fibronectin and intercellular cell adhesion molecule-1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Gong W; Chen C; Xiong F; Yang Z; Wang Y; Huang J; Liu P; Huang H
Biochem Pharmacol; 2016 Sep; 116():140-52. PubMed ID: 27481061
[TBL] [Abstract][Full Text] [Related]
9. The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-β1 expressions in rat glomerular mesangial cells.
Huang K; Gao X; Wei W
Exp Cell Res; 2017 Dec; 361(1):63-72. PubMed ID: 28986066
[TBL] [Abstract][Full Text] [Related]
10. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
[TBL] [Abstract][Full Text] [Related]
11. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
Wang S; Zhao X; Yang S; Chen B; Shi J
Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
13. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
14. BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells.
Wu X; Pan C; Chen R; Zhang S; Zhai Y; Guo H
Int Immunopharmacol; 2020 Feb; 79():106108. PubMed ID: 31881376
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
16. Ampelopsin inhibits high glucose-induced extracellular matrix accumulation and oxidative stress in mesangial cells through activating the Nrf2/HO-1 pathway.
Dong C; Wu G; Li H; Qiao Y; Gao S
Phytother Res; 2020 Aug; 34(8):2044-2052. PubMed ID: 32155298
[TBL] [Abstract][Full Text] [Related]
17. Phelligridin D from Inonotus obliquus attenuates oxidative stress and accumulation of ECM in mesangial cells under high glucose via activating Nrf2.
Li Y; Zhou Y; Wu J; Li J; Yao H
J Nat Med; 2021 Sep; 75(4):1021-1029. PubMed ID: 34052991
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection.
Chi F; Cheng C; Zhang M; Su B; Hou Y; Bai G
J Ethnopharmacol; 2024 Oct; 332():118353. PubMed ID: 38762209
[TBL] [Abstract][Full Text] [Related]
19. Acteoside inhibits high glucose-induced oxidative stress injury in RPE cells and the outer retina through the Keap1/Nrf2/ARE pathway.
Yang J; Hua Z; Zheng Z; Ma X; Zhu L; Li Y
Exp Eye Res; 2023 Jul; 232():109496. PubMed ID: 37268044
[TBL] [Abstract][Full Text] [Related]
20. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
